BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nabil M, Gruber T, Yakoub D, Ackermann H, Zangos S, Vogl TJ. Repetitive transarterial chemoembolization (TACE) of liver metastases from renal cell carcinoma: Local control and survival results. Eur Radiol 2008;18:1456-63. [DOI: 10.1007/s00330-008-0887-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Abdelmaksoud MH, Louie JD, Hwang GL, Kothary N, Minor DR, Sze DY. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver. J Vasc Interv Radiol. 2012;23:323-330.e1. [PMID: 22277275 DOI: 10.1016/j.jvir.2011.11.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
2 Tak E, Lee S, Lee J, Rashid M, Kim YW, Park J, Park WS, Shokat KM, Ha J, Kim SS. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. Journal of Hepatology 2011;54:328-39. [DOI: 10.1016/j.jhep.2010.06.045] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
3 Vogl TJ, Kreutzträger M, Gruber-Rouh T, Eichler K, Nour-Eldin NE, Zangos S, Naguib NN. Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates. Eur J Radiol 2014;83:1804-10. [PMID: 25082479 DOI: 10.1016/j.ejrad.2014.06.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
4 Carrafiello G, Dionigi G, Boni L, Mangini M, Ierardi AM, Piacentino F, Di Massa A, Nocchi Cardim L, Biondi A, Fugazzola C. Current role of interventions in metastatic kidney tumors: single center experience. Updates Surg 2011;63:259-69. [PMID: 22065381 DOI: 10.1007/s13304-011-0118-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
5 Schwaner SL, Haug SB, Matsumoto AH. Overview of Embolotherapy: Agents, Indications, Applications, and Nursing Management. Perioperative Nursing Clinics 2010;5:137-76. [DOI: 10.1016/j.cpen.2010.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol. 2009;16:423-430. [PMID: 19050974 DOI: 10.1245/s10434-008-0222-6] [Cited by in Crossref: 104] [Cited by in F6Publishing: 84] [Article Influence: 7.4] [Reference Citation Analysis]
7 Vogl TJ, Marko C, Langenbach MC, Naguib NNN, Filmann N, Hammerstingl R, Gruber-Rouh T. Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial. Eur Radiol 2021;31:2242-51. [PMID: 32960329 DOI: 10.1007/s00330-020-07253-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kis B, Shah J, Choi J, El-Haddad G, Sweeney J, Biebel B, Mellon E, Frakes JM, Hoffe SE, Fishman MN, Shridhar R. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma. J Vasc Interv Radiol 2017;28:254-9. [PMID: 27955832 DOI: 10.1016/j.jvir.2016.09.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
9 Fleckenstein FN, Schernthaner RE, Duran R, Sohn JH, Sahu S, Marshall K, Lin M, Gebauer B, Chapiro J, Salem R, Geschwind JF. Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis. Transl Oncol 2016;9:377-83. [PMID: 27641641 DOI: 10.1016/j.tranon.2016.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gadaleta CD, Ranieri G. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors. Crit Rev Oncol Hematol. 2011;80:40-53. [PMID: 21067940 DOI: 10.1016/j.critrevonc.2010.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
11 Goerg F, Zimmermann M, Bruners P, Neumann U, Luedde T, Kuhl C. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study. Cardiovasc Intervent Radiol 2019;42:1709-17. [PMID: 31578633 DOI: 10.1007/s00270-019-02344-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Matsuda H, Tamada S, Kato M, Yamamoto A, Iguchi T, Nakatani T. Transarterial chemoembolization of liver metastasis from renal cell carcinoma. Urol Case Rep 2018;17:79-81. [PMID: 29541587 DOI: 10.1016/j.eucr.2018.01.015] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]